We tested the hypothesis that curcumin supplementation would reverse arterial dysfunction and vascular oxidative stress with aging. Young (Y, 4-6 mo) and old (O, 26-28 mo) male C57BL6/N mice were given normal or curcumin supplemented (0.2%) chow for 4 weeks (n = 5-10/group/ measure). Large elastic artery stiffness, assessed by aortic pulse wave velocity (aPWV), was greater in O (448 ± 15 vs. 349 ± 15 cm/s) and associated with greater collagen I and advanced glycation end-products and less elastin (all P < 0.05). In O, curcumin restored aPWV (386 ± 15 cm/s), collagen I and AGEs to levels not different vs. Y. Ex vivo carotid artery acetylcholine (ACh)-induced endothelial-dependent dilation (EDD, 79 ± 3 vs. 94 ± 2%), nitric oxide (NO) bioavailability and protein expression of endothelial NO synthase (eNOS) were lower in O (all P < 0.05). In O, curcumin restored NO-mediated EDD (92 ± 2%) to levels of Y. Acute ex vivo administration of the superoxide dismutase (SOD) mimetic TEMPOL normalized EDD in O control mice (93 ± 3%), but had no effect in Y control or O curcumin treated animals. O had greater arterial nitrotyrosine abundance, superoxide production and NADPH oxidase p67 subunit expression, and lower manganese SOD (all P < 0.05), all of which were reversed with curcumin. Curcumin had no effects on Y. Curcumin supplementation ameliorates age-associated large elastic artery stiffening, NO-mediated vascular endothelial dysfunction, oxidative stress and increases in collagen and AGEs in mice. Curcumin may be a novel therapy for treating arterial aging in humans.
Introduction
Cardiovascular diseases (CVD) are the leading cause of mortality in the United States and advancing age is the primary risk factor for CVD (Roger and others, 2012) . Arterial dysfunction with aging, characterized by large elastic artery stiffening and endothelial dysfunction, contributes importantly to the increase in CVD risk with aging (Lakatta and Levy, 2003) . Increases in large elastic artery stiffness with aging, as shown by the gold standard clinical measure of aortic pulse wave velocity (aPWV) (Laurent and others, 2006; Vlachopoulos and others, 2010) , is believed to be mediated in part by increases in collagen I deposition, reductions in elastin and modifications of these and other proteins by advanced glycation end-products (AGEs) (Lakatta and Levy, 2003; Zieman and others, 2005) . Agerelated endothelial dysfunction, as indicated by impaired endothelium-dependent dilation (EDD), is a consequence of reduced nitric oxide (NO) bioavailability (Celermajer and others, 1994; d'Uscio and others, 1997; Taddei and others, 1995) that may or may not be associated with changes in the NO-synthesizing enzyme endothelial nitric oxide synthase (eNOS) (Brandes and others, 2005; Muller-Delp, 2006; Seals and others, 2012) .
Oxidative stress, as indicated by increased oxidant modification of biomolecules such as nitration of tyrosine residues on proteins (i.e., nitrotyrosine) (Radi, 2004) , plays an important role in arterial aging (Brandes and others, 2005; Donato and others, 2007; Seals and others, 2012) . Vascular oxidative stress with aging is mediated by excessive bioavailability of superoxide, which is associated with both increased expression of the p67 subunit of the oxidant enzyme NADPH oxidase (NOX) and reduced expression of the mitochondrial antioxidant enzyme manganese superoxide dismutase (MnSOD) (Donato and others, 2007; Fleenor and others, 2012; Pierce and others, 2011; Rippe and others, 2010; Sindler and others, 2011) . Recently, we have shown excessive arterial superoxide production with aging in mice measured directly with electron paramagnetic resonance spectroscopy (Fleenor and others, 2012; Rippe and others, 2010; Sindler and others, 2011) , and that both acute (Durrant and others, 2009; Rippe and others, 2010; Sindler and others, 2011) and chronic (Fleenor and others, 2012) treatment with the SOD mimetic and superoxide scavenger, TEMPOL, reverses large elastic artery stiffening and/or endothelial dysfunction in old mice. Therefore, interventions that normalize superoxide-dependent oxidative stress and can be safely administered to humans have the translational potential to improve large elastic artery stiffening and endothelial dysfunction with aging in humans.
Curcumin, from the plant curcuma longa, is a safe, naturally occurring polyphenol found in the Indian spice turmeric that has long been used in traditional Indian medicine (Miriyala and others, 2007) . In some models of disease, supplementation with curcumin lowers superoxide/oxidative stress (Nakmareong and others, 2011b) and improves vascular dysfunction in young animals (Majithiya and Balaraman, 2005; Nakmareong and others, 2011b; Rungseesantivanon and others, 2010) . Curcumin increases MnSOD expression in cultured esophageal cells (Schiffman and others, 2012) and extends lifespan (Kitani and others, 2004; Kitani and others, 2007) in non-disease mouse models. Moreover, curcumin is a readily accessible and has a good safety record in clinical trials (Cheng and others, 2001) . It is unknown, however, if dietary curcumin supplementation can reverse age-related arterial dysfunction and oxidative stress.
In the present study, we tested the hypothesis that 4 weeks of dietary supplementation with curcumin would reduce large elastic artery stiffness, reverse age-associated changes in arterial collagen I, elastin and/or AGEs, and improve endothelial function by increasing NO bioavailability in old mice. We also tested the hypothesis that curcumin would normalize arterial oxidative stress and that this would be associated with reduced superoxide production and NOX expression, as well as increased expression of MnSOD.
Methods

Animals
Young (4-6 months) and old (26-28 months) male C57BL/6N mice at ages corresponding to ~25 and 75 year old humans, respectively (Flurkey and others, 2007) , were purchased from the National Institute of Aging rodent colony. All mice were housed at the University of Colorado at Boulder in a 12:12 light:dark cycle vivarium and had ad libitum access to water and rodent chow. For 4 weeks, control mice were given normal rodent chow and treated mice were given curcumin-supplemented food at a dose (0.2%, Harlan) shown to increase survival in C57BL/6 mice (Kitani and others, 2004; Kitani and others, 2007 
Aortic Pulse Wave Velocity
aPWV was assessed non-invasively as previously described by our laboratory and others (Fleenor and others, 2012; Kim and others, 2009; Reddy and others, 2003; Sindler and others, 2011) . Briefly, isoflurane (2%) was used to anesthetize mice that were placed supine with legs secured to ECG electrodes on a heated board. Doppler probes were placed on the skin at the transverse aortic arch and abdominal aorta ~4 cm apart. For each site, the preejection time, or time between the R-wave of the ECG to the foot of the Doppler signal was determined. To calculate aPWV, the distance between the probes was divided by the difference in the thoracic and abdominal pre-ejection times and is presented as centimeters/ second (cm/s). Following aPWV measures, mice were euthanized by exsanguination via cardiac puncture while anesthetized with isoflurane.
Immunohistochemistry
Standard immunohistochemistry procedures and quantification were performed as previously described by our laboratory (Fleenor and others, 2010; Fleenor and others, 2012) . Liquid nitrogen cooled isopentane was used to freeze aortic segments in optimal cutting temperature compound (Fisher Scientific). Acetone fixed sections (7 µm) were stained in a single batch with the Dako EnVision+ System-HRP-DAB kit as recommended by the manufacturer (Dako) with primary antibodies incubated at 4° C for 1 hour. A labeled polymer secondary was applied for 30 minutes, and 2-minute exposure to diaminobenzidine was used to visualize the staining. Slides were dehydrated in alcohols (50%, 75%, 80%, 95%, 100%), cleared in xylenes and cover-slipped. A Nikon Eclipse TS100 photomicroscope captured digital images at a 4X magnification that were analyzed with Image-Pro Plus software (Media Cybernetics). Primary antibodies used were specific for collagen I (1:4000, Millipore), alpha elastin (1:25, Abcam) and AGEs (1:200, GeneTex). A negative control was performed for each antibody.
Carotid artery vasodilatory responses
Ex vivo carotid artery endothelium-dependent (EDD) and endothelium-independent dilations were assessed as previously described in detail (Durrant and others, 2009; Fleenor and others, 2012; Rippe and others, 2010; Sindler and others, 2011) . To determine EDD, increases in inner luminal diameter were assessed in response to acetycholine (ACh, 1 X 10 −9 -1 X 10 −4 M) with and without the co-administration of the NO synthase inhibitor N-G-nitro-L-arginie (L-NAME, 0.1 mM, 30 minute incubation), or the SOD mimetic, TEMPOL (1mM, 60 minute incubation) after a submaximal preconstriction with phenylephrine (2 µm). Sodium nitroprusside (SNP: 1 X 10 −10 -1 X 10 −4 M) was used to assess endotheliumin-dependent dilation.
All dose response data are presented on a percent basis. Preconstriction was calculated as a percentage of maximal diameter as previously described (Durrant and others, 2009; Fleenor and others, 2012; Rippe and others, 2010; Sindler and others, 2011) . NO-dependent dilation was determined from the maximal EDD in the absence or presence of L-NAME according to the following formula:
Aortic superoxide production
Electron paramagnetic resonance (EPR) spectrometry was used to measure superoxide production as described previously (Fleenor and others, 2012; Rippe and others, 2010; Sindler and others, 2011) . Briefly, 2-millimeter aortic rings cleaned of perivascular fat were incubated at 37° C in 200 µl of Krebs-HEPES buffer with the 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (Alexis Biochemicals) spin trap for 60 minutes. After incubation the samples were analyzed immediately on an MS300 X-band EPR spectrometer (Magnettech).
Western blotting
Protein expression was determined in aortic samples by western blotting as previously described (Durrant and others, 2009; Fleenor and others, 2012; Rippe and others, 2010; Sindler and others, 2011) . Aortas were cleaned of the surrounding perivascular fat, snap frozen in liquid nitrogen and stored at −80° C. Samples were homogenized in RIPA lysis buffer that had protease and phosphatase inhibitors (Roche) as well as a 0.01% phosphatase inhibitor cocktail (Sigma). Protein (10 micrograms/lane) was loaded in a 4-12% polyacrylamide gradient gel that was separated by electrophoresis and transferred to a nitrocellulose membrane. Membranes were probed with primary antibodies specific for collagen I (1:1000, Millipore), alpha elastin (1:100, abcam), AGEs (1:1000, GeneTex), nitrotyrosine (1:100, Abcam), NOX subunit, p67 (1:1000, Cell Signaling), MnSOD (1:1000, Stressgen), ecSOD (1:500, Sigma), CuZnSOD (1:2000, Stressgen), and endothelial NO synthase (1:500, BD Biosciences). ImageJ software (NIH) was used to analyze the bands that were normalized to β-tubulin and expressed relative to the control group.
Statistical analysis
Analyses were performed with SPSS version 19 software (IBM) and all data are presented as mean ± S.E.M. A two-way ANOVA was used to analyze aPWV, immunohistochemistry, superoxide and western blots. For vessel dilation studies, a two-way repeated measures ANOVA was used to analyze the data. Least square differences post hoc tests were used where appropriate. Significance was set at P < 0.05.
Results
Animal characteristics
Animal characteristics are presented by group (n = 5-10/group) in Table 1 . Body mass, heart mass and maximal carotid diameter was greater in old compared with young control mice (P < 0.05). Food intake and heart rate did not differ with age. Young curcumin supplemented animals had greater body mass compared with young controls (P < 0.05), and greater food intake compared with all other groups (P < 0.05). Curcumin consumption was greater in young compared with old treated animals (P < 0.05). Heart mass, heart:body weight ratio, heart rate and maximal carotid diameter were not significantly different in curcumin treated mice compared with controls.
aPWV and aortic collagen I, elastin and AGEs
Old control mice had greater aPWV compared with young controls (P < 0.05, Figure 1 ). Curcumin reduced aPWV in old mice to levels not significantly different from young controls, but had no effect in young animals.
Collagen I was greater in the whole aorta (Figure 2A ) and in the adventitial layer ( Figure 2B and 2C) of old compared with young control mice (P < 0.05). Curcumin normalized collagen in the whole aorta and adventitial layer of old animals (P < 0.05) without affecting expression of young treated mice. Elastin was lower in the whole aorta and medial layer of old compared with young control mice (P < 0.05, Table 2 ). Curcumin treatment did not affect elastin expression in either age group.
AGEs were greater in the whole aorta ( Figure 2D ) and in the medial and adventitial layers ( Figure 2E and 2F ) of old compared with young control animals (P < 0.05). Curcumin supplementation completely normalized AGEs in the whole aorta, media and adventitial layers in old mice (P < 0.05), without affecting levels in young mice.
Vascular endothelial function: modulation by NO bioavailability and oxidative stress
ACh-induced EDD was reduced in old compared with young control mice (P < 0.05, Figure  3A ), due to a diminished NO dilatory influence as shown by a smaller decrease in EDD with the NO inhibitor L-NAME (P < 0.05, Figure 3A and 3B). Curcumin restored NO-mediated EDD in old mice to levels not significantly different to young control values ( Figure 3A and 3B). Curcumin had no effect on NO-mediated EDD in young treated mice. Acute ex vivo administration of the superoxide dismutase mimetic TEMPOL normalized ACh induced EDD in carotids from old animals, while not affecting responses in young control or young and old curcumin-treated animals ( Figure 3C ). Maximal endothelium-independent dilation to sodium nitroprusside was not different among the groups, although an effect of age was observed at the lower doses ( Figure 3D ). Protein expression of the NO-synthesizing enzyme eNOS was reduced in old compared with young control mice (P < 0.05, Table 3 ). Curcumin did not affect eNOS in either young or old mice.
Arterial oxidative stress, superoxide production, NOX and SOD antioxidant enzymes
Arterial nitrotyrosine abundance at the 55kDa band and superoxide production were greater in old compared with young control mice (P < 0.05, Figure 4A , 4B and 4C). Curcumin ameliorated the excessive nitrotyrosine abundance of the 55kDA band in aorta of old mice (P < 0.05), without affecting nitrotyrosine in young treated animals. Curcumin reduced aortic superoxide production in both young and old treated animals to levels below young control values (P < 0.05). No group differences were observed in arterial nitrotyrosine staining at the 25kDa band ( Figure 4B , quantification not shown).
Expression of the p67 subunit of NOX was greater in aorta from old compared with young control mice (P < 0.05, Figure 5A ). Curcumin treatment normalized p67 expression in old mice (P < 0.05), but had no effect in young treated animals. Antioxidant expression of MnSOD was reduced in old compared to young control mice (P < 0.05, Figure 5B ), and curcumin supplementation increased MnSOD expression in old mice to levels not significantly different from young control animals. Neither ecSOD nor CuZnSOD were affected by age or curcumin treatment (Table 3) .
Discussion
The present study demonstrates for the first time that dietary curcumin supplementation ameliorates age-related large elastic artery stiffening and vascular endothelial dysfunction. Advancing age is the major risk factor for CVD and arterial dysfunction explains much of this increased risk (Lakatta and Levy, 2003) . Therefore, these preclinical findings provide important evidence for curcumin as a novel, accessible and cost-effective intervention to improve arterial dysfunction and possibly reduce CVD risk with aging in humans. Our results also provide insight into the mechanisms by which curcumin may improve age-related arterial dysfunction. These include amelioration of oxidative stress, normalization of collagen I deposition and AGES, and restoration of NO bioavailability.
Large elastic artery stiffness
The present findings are consistent with previous work from our laboratory (Fleenor and others, 2012; Sindler and others, 2011) and others (Reddy and others, 2003; Soucy and others, 2006) showing that aging results in increased aPWV, the most important clinical measurement of large elastic artery stiffness in humans (Vlachopoulos and others, 2010) . Our current observations extend these previous findings by demonstrating that 4 weeks of dietary curcumin treatment in old mice reduces aPWV to levels not significantly different from young control mice. Curcumin supplementation did not affect aPWV in young treated animals, suggesting that improvements with treatment were specific in old animals. These findings are of clinical significance for older humans because increased aPWV is a strong independent predictor of adverse cardiovascular events and all cause mortality (Mitchell and others, 2010; Vlachopoulos and others, 2010) . Thus, our preclinical findings here provide the first support for the idea that curcumin may have efficacy for improving large elastic artery stiffness in middle-aged and older adults.
Age-associated large elastic artery stiffness is mediated in part by structural changes that include increased collagen I deposition, reductions in elastin and modifications of these proteins by AGEs (Kass and others, 2001; Lakatta and Levy, 2003) . In the present study, collagen I, the major arterial collagen isoform, was increased overall and in the adventitial layer of the aorta as we have reported recently (Fleenor and others, 2010; Fleenor and others, 2012) , whereas elastin is reduced overall and within the media (Csiszar and others, 2007; Fleenor and others, 2010; Fleenor and others, 2012; Wang and Lakatta, 2002) . AGEs were increased overall and in both the medial and adventitial layers of aorta in old control mice as observed previously by our lab (Fleenor and others, 2012) and others (Qiu and others, 2007) . Curcumin supplementation reversed these age-associated increases in collagen I and AGEs in a manner consistent with the decreases in aPWV observed. These results are in general agreement with prior reports that curcumin reverses collagen expression in vascular and lung injury models (Smith and others, 2010; Yang and others, 2006) and prevents AGEs accumulation in diabetic rats (Sajithlal and others, 1998) . Although reported to prevent elastin degradation in a preclinical model of aneurysm (Parodi and others, 2006) , curcumin did not influence elastin in the aortas of our old mice.
Vascular endothelial dysfunction
The current findings are in agreement with previous reports from our laboratory (Durrant and others, 2009; Fleenor and others, 2012; Rippe and others, 2010; Sindler and others, 2011) demonstrating EDD is impaired in large elastic arteries of old mice due to a smaller NO-mediated dilatory component that is associated with reduced eNOS protein expression. In the present study we show that curcumin supplementation ameliorated the impairment in EDD with aging by restoring NO-dependent dilation to levels not different than young mice. This observation is consistent with previous reports in animal models of clinical disorders including diabetes (Chai and others, 2005; Majithiya and Balaraman, 2005; Ramaswami and others, 2004; Rungseesantivanon and others, 2010) . In contrast to results from disease models (Chai and others, 2005; Nakmareong and others, 2011a; Nakmareong and others, 2011b; Ramaswami and others, 2004) , the present findings show that curcumin restored EDD in old mice without increasing expression of eNOS. The SOD mimetic, TEMPOL, restored the impaired EDD observed in old mice as reported previously by our laboratory (Durrant and others, 2009; Lesniewski and others, 2009; Lesniewski and others, 2011; Sindler and others, 2011) without having an effect in young or old curcumin treated mice.
These data support the notion that the superoxide lowering effect of curcumin in old mice is responsible for the improvement in endothelial function.
Oxidative Stress
Our finding of increased arterial nitrotyrosine abundance, a cellular marker of oxidative stress, in old mice is consistent with our previous observations (Durrant and others, 2009; Fleenor and others, 2012; Sindler and others, 2011) . Nitrotyrosine modifications are a result of a posttranslational nitration of tyrosine residues primarily mediated by peroxynitrite, which is a by-product of the reaction between superoxide and NO (Radi, 2004) . The oxidative stress seen in old mice is associated with greater aortic superoxide production and p67 subunit expression of NOX, a pro-oxidant enzyme, and reductions in the mitochondrial anti-oxidant enzyme MnSOD, as we recently reported (Fleenor and others, 2012; Sindler and others, 2011 ).
The present results extend this prior work by demonstrating that curcumin supplementation normalizes aortic nitrotyrosine staining in old mice, indicating amelioration of ageassociated vascular oxidative stress. This is consistent with previous work reporting reduced oxidative stress after treatment with curcumin in models of hemorrhage and cardiovascular disease, as well as in animals treated with lipopolysaccharide or L-NAME (Nakmareong and others, 2011a; Nakmareong and others, 2011b; Quiles and others, 2002; Sompamit and others, 2009; Wakade and others, 2009 ). Here we show that the antioxidant effect of curcumin in old mice is, at least in part, attributable to reductions in aortic superoxide production, directly measured by EPR spectroscopy. Results of previous reports assessing superoxide with fluorescent dyes in models of clinical disorders are in agreement with the present findings (Chai and others, 2005; Sompamit and others, 2009; Wakade and others, 2009) . Curcumin restored expression of the p67 subunit of oxidant enzyme NOX and the mitochondrial antioxidant enzyme MnSOD in old mice to young control levels, suggesting that both production and dismutation of superoxide is enhanced with curcumin (Awad, 2011; Lakshmanan and others, 2011) . In addition to altering pro-and anti-oxidant enzyme expressions, our data suggest that curcumin may also directly scavenge free radicals, as indicated previously (Chai and others, 2005; Ramaswami and others, 2004) .
Curcumin
Asian cultures that widely use turmeric in cooking consume an estimated 1.5 -2.5 g/d of this compound, which is ~60-100 mg/d of curcumin for a 60 kg person (Eigner and Scholz, 1999; Miriyala and others, 2007; Shah and others, 1999 ). In the current study, we used a dose of curcumin that has been reported to increase longevity in rodents (Kitani and others, 2004; Kitani and others, 2007) , and the mice received the equivalent of 19 (young group) and 14 (old group) g of curcumin when compared with a 60 kg person. Because of curcumin's poor absorption and rapid metabolism (Wahlstrom and Blennow, 1978) , clinical trials in humans also have used high doses of curcumin (~8-12 g) similar to the amount our old mice consumed, while observing only infrequent, minor side effects (Cheng and others, 2001 ).
Although we did not assess plasma curcumin in the present study, the same dose of curcumin used here previously has been shown to produce measurable concentrations of this compound in plasma of mice (Perkins and others, 2002) . Curcumin consumed orally is metabolized primarily in the intestine, resulting in the production of biologically active metabolites. An increase in these metabolites may be responsible for improvements in health and arterial function observed in the current study (Ahn and others, 2009; Nakmareong and others, 2011b) . Moreover, it is important to note that curcumin is metabolized much more extensively in human compared with rodent intestinal tissues (Ireson and others, 2002; Sharma and others, 2005) . Thus, it is possible that curcumin may have greater bioavailability and effects in rodents. To improve delivery and efficacy, manufacturers recently have developed curcumin formulations that enhance bioavailability and slow metabolism, thus allowing low-dose (e.g., 0.5 g) capsules to be used and further increasing the translational potential of the compound (Gota and others, 2010).
Finally, food intake and body mass were ~20% greater in curcumin-supplemented compared with chow-fed young mice in the present study. This effect of curcumin in young animals has been reported previously (Weisberg and others, 2008) and was not observed in the old mice in our study. Most importantly, the higher food intake and body mass in the young curcumin-treated animals was not associated with differences in arterial function or the other primary outcomes of the study.
Conclusions
Our results provide the first evidence that dietary curcumin supplementation ameliorates two clinically important markers of arterial dysfunction with aging: large elastic artery stiffening and endothelial dysfunction. Moreover, the present results provide insight into the mechanisms of action, including normalization of vascular superoxide production and oxidative stress, reductions in collagen I and AGES in the arterial wall, and restoration of NO bioavailability. Given its accessibility and safety, these pre-clinical findings provide the experimental basis for future translational studies assessing the potential for curcumin to treat arterial dysfunction with aging and reduce CVD risk in humans.
Highlights
In old animals, 4 week curcumin supplementation:
• Reverses large elastic artery stiffness
• Ameliorates endothelial dysfunction
• Attenuates arterial superoxide production and oxidative stress Curcumin is a promising antioxidant therapy to treat age-related arterial dysfunction. Aortic nitrotyrosine abundance quantified at the 55kDa band by western blot of whole artery lysates (A), representative western blot (B) and mean electron paramagnetic resonance signal (C) in young and old control (YC and OC) and young and old curcumin supplemented (YCUR and OCUR) mice (n = 3-8/group). Values are mean ± S.E.M. * P < 0.05 vs. YC, YCUR, and OCUR. † P < 0.05 vs. YC and OC. Exp Gerontol. Author manuscript; available in PMC 2014 February 01.
